Levee Medical
  • Home
  • Product
  • Clinical
  • Publications
  • News
  • Company
  • Contact
Select Page

Levee Medical® Announces First Patient Enrolled in ARID II IDE Pivotal Trial

by Kristen Lomas | Apr 24, 2025 | Press Releases

Durham, NC – April 24, 2025 – Levee Medical®, a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced the enrollment of the first patient in its landmark ARID II pivotal trial. This marks a significant milestone in...

Levee Medical Receives FDA Approval for its Landmark ARID II IDE Pivotal Study

by Kristen Lomas | Mar 5, 2025 | Press Releases

Multicenter, randomized controlled pivotal study to investigate a novel device for post-radical prostatectomy stress urinary incontinence Durham, NC – March 4, 2025 – Levee Medical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted...

Levee Medical® Secures $10 Million in Oversubscribed Series B Funding

by Kristen Lomas | Feb 13, 2025 | Press Releases

Funding to Advance Voro® Urologic Scaffold Development and Clinical Studies Durham, NC – February 11, 2025 – Levee Medical®, a medical device company focused on improving outcomes for prostate cancer surgery patients, announced the successful close of its Series B...
Next Entries »

Levee Medical
4819 Emperor Blvd, Suite 400
Durham, NC 27703

info@leveemedical.com

+1 (919) 313-4520

Careers
Interested in joining our exciting and growing team: Contact Us

*https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html

The Voro™ Urologic Scaffold is an investigational device not approved for sale in any country. CAUTION – Investigational device. Limited by Federal Law to investigational use. Levee Medical, the logo, and all products names on this site are trademarks of Levee Medical unless otherwise noted. No use is permitted without prior written authorization.

©2025 Levee Medical. All rights reserved.   Privacy Policy  |  Terms